| cocaine use disorder |
phenotype |
17 |
13 |
cocaine, cocaine addicts, cocaine consumption, cocaine use, cocaine users, cocaine-dependent participants, ever used cocaine, individuals with cocaine use disorder |
| codeine |
drug |
2 |
2 |
|
| coding variant |
cohort |
6 |
1 |
coding variants, damaging coding variants |
| coffee |
drug |
5 |
1 |
|
| COGA dataset |
cohort |
5 |
2 |
COGA |
| COGA sample |
cohort |
28 |
15 |
COGA, COGA GWAS, COGA GWAS sample, Collaborative Study on the Genetics of Alcoholism, collaborative study on the genetics of alcoholism (COGA) |
| COGA sites |
cohort |
2 |
— |
COGA sites |
| COGEND |
cohort |
19 |
13 |
COGEND, COGEND data, Collaborative Genetic Study of Nicotine Dependence, Collaborative Study on the Genetics of Nicotine Dependence, genetics of nicotine dependence study |
| cognition |
phenotype |
114 |
76 |
CP, Cognitive impairment, Higher cognitive processes, alcohol-related cognitive impairments, attention, attentional function, cognition, cognition deficits, cognitive changes, cognitive decline, cognitive deficits, cognitive function, cognitive functioning, cognitive functioning impairments, cognitive functions, cognitive impairment, cognitive impairments, cognitive performance, cognitive profiles, cognitive symptoms, cognitive tasks, cognitive-functioning impairments, cognitive-impairing effects, deficits in cognitive functions, deficits in nonverbal tasks, downstream cognitive functioning, executive functions, impairment of cognitive functions, impairments across several domains of complex cognitive function, impairments on cognitive measures, individual differences in cognition, neuropsychological abnormalities, normal cognitive performance, overall cognitive functioning, performance on cognitive tasks, poor working memory, poorer cognitive ability, poorer cognitive functioning |
| cognitive ability |
phenotype |
17 |
7 |
ability, adult general cognitive ability, cognitive ability, cognitive ability test scores, cognitive function, cognitive impairment, measures of cognitive ability |
| Cognitive behavioral therapy |
drug |
3 |
1 |
CBT, ERP, exposure response prevention |
| Cognitive changes |
phenotype |
2 |
2 |
|
| cognitive control |
phenotype |
16 |
13 |
capacity to effectively engage cognitive control, cognitive control, cognitive control abilities, cognitive control capacity, cognitive control task, cognitive performance, control capacity, delay of immediate gratification, executive control, executive function, temptation resistance |
| cognitive decline |
phenotype |
13 |
8 |
cognitive decline, cognitive impairment, rate of cognitive decline |
| cognitive development |
phenotype |
3 |
1 |
|
| cognitive flexibility |
phenotype |
10 |
4 |
3-year cognitive flexibility, DCCS, cognitive flexibility, cognitive flexibility at age 3 |
| cognitive measures |
phenotype |
6 |
2 |
cognitive performance, cognitive scores, neurocognitive |
| Cognitive outcomes |
phenotype |
4 |
— |
|
| cognitive phenotypes |
phenotype |
5 |
3 |
|
| cognitive processes |
phenotype |
12 |
9 |
cognition, cognitive processes, cognitive tasks, mental operations |
